AML

When would you consider a repeat induction regimen for AML versus a salvage regimen?

Older patients, young patient with low burden refractory disease, hypocellular marrow, 10- 20% blasts,
High tumor burden primary refractory disease likely requires salvage therapy

en_USEnglish